A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy
Devy Deliyanti, Jae Young Lee, Steven Petratos, Colin J Meyer, Keith W Ward, Jennifer L Wilkinson-Berka, Judy B de Haan
Clinical Science | PORTLAND PRESS LTD | Published : 2016
Awarded by Trish Multiple Sclerosis Research Foundation
Awarded by National Multiple Sclerosis Society
This work was supported by the Multiple Sclerosis Research Australia Postgraduate Scholarship (to J.Y.L.); the Trish Multiple Sclerosis Research Foundation [grant number #12-060 (to J.Y.L.)]; the National Multiple Sclerosis Society Project [grant number RG4398A1/1 (to S.P.)]; the Reata Pharmaceuticals, Inc. (to J.B.dH.); and the Victorian Government's Operational Infrastructure Support Program.